Literature DB >> 27068427

P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.

Fabian Z Burkhard1, Shaheena Parween1, Sameer S Udhane1, Christa E Flück1, Amit V Pandey2.   

Abstract

Cytochrome P450 oxidoreductase (POR) is required for metabolic reactions of steroid and drug metabolizing cytochrome P450 proteins located in endoplasmic reticulum. Mutations in POR cause a complex set of disorders resembling combined deficiencies of multiple steroid metabolizing enzymes. The P450 oxidoreductase deficiency (PORD) was first reported in patients with symptoms of defects in steroidogenic cytochrome P450 enzymes and ambiguous genitalia, and bone malformation features resembling Antley-Bixler syndrome. POR is now classified as a separate and rare form of congenital adrenal hyperplasia (CAH), which may cause disorder of sexual development (DSD). Since the initial description of PORD in 2004, a large number of POR mutations and polymorphisms have been described. In this report we have performed computational analysis of mutations and polymorphisms in POR linked to metabolism of steroids and xenobiotics and pathology of PORD from the reported cases. The mutations in POR that were identified in patients with disruption of steroidogenesis also have severe effects on cytochrome P450 proteins involved in metabolism of drugs. Different variations in POR show a range of diverse effects on different partner proteins that are often linked to the location of the particular variants. The variations in POR that cause defective binding of co-factors always have damaging effects on all partner proteins, while the mutations causing subtle structural changes may lead to altered interaction with partner proteins and the overall effect may be different for each individual partner. Computational analysis of available sequencing data and mutation analysis shows that Japanese (R457H), Caucasian (A287P) and Turkish (399-401) populations can be linked to unique founder mutations. Other mutations identified so far were identified as rare alleles or in single isolated reports. The common polymorphism of POR is the variant A503V which can be found in about 27% of alleles in general population but there are remarkable differences among different sub populations. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antley-Bixler syndrome; CYP17A1; Cytochrome P450 oxidoreductase; Disorders of sexual development; P450 oxidoreductase deficiency; PORD; Steroid metabolism

Mesh:

Substances:

Year:  2016        PMID: 27068427     DOI: 10.1016/j.jsbmb.2016.04.003

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  18 in total

Review 1.  Monogenic Disorders of Adrenal Steroidogenesis.

Authors:  Elizabeth S Baranowski; Wiebke Arlt; Jan Idkowiak
Journal:  Horm Res Paediatr       Date:  2018-06-06       Impact factor: 2.852

2.  Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition.

Authors:  Evan D Kharasch; Amanda Crafford
Journal:  Clin Pharmacol Ther       Date:  2018-08-09       Impact factor: 6.875

3.  Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants.

Authors:  Pan-Fen Wang; Alicia Neiner; Evan D Kharasch
Journal:  Drug Metab Dispos       Date:  2020-04-01       Impact factor: 3.922

4.  Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency.

Authors:  Yena Lee; Jin-Ho Choi; Arum Oh; Gu-Hwan Kim; Sook-Hyun Park; Jung Eun Moon; Cheol Woo Ko; Chong-Kun Cheon; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-06-30

Review 5.  46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.

Authors:  Federico Baronio; Rita Ortolano; Soara Menabò; Alessandra Cassio; Lilia Baldazzi; Valeria Di Natale; Giacomo Tonti; Benedetta Vestrucci; Antonio Balsamo
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

Review 6.  Cytochrome P450 oxidoreductase deficiency caused by a novel mutation in the POR gene in two siblings: case report and literature review.

Authors:  Edip Unal; Meliha Demiral; Ruken Yıldırım; Funda Feryal Taş; Serdar Ceylaner; Mehmet Nuri Özbek
Journal:  Hormones (Athens)       Date:  2020-10-29       Impact factor: 2.885

7.  Orchestrated Domain Movement in Catalysis by Cytochrome P450 Reductase.

Authors:  Samuel L Freeman; Anne Martel; Emma L Raven; Gordon C K Roberts
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

8.  Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.

Authors:  Mónica Fernández-Cancio; Núria Camats; Christa E Flück; Adam Zalewski; Bernhard Dick; Brigitte M Frey; Raquel Monné; Núria Torán; Laura Audí; Amit V Pandey
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-29

9.  Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase.

Authors:  Shaheena Parween; Maria Natalia Rojas Velazquez; Sameer S Udhane; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

10.  Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.

Authors:  Sameer S Udhane; Shaheena Parween; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.